Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Small fiber neuropathy in coeliac disease and gluten sensitivity.

Zis P, Sarrigiannis PG, Rao DG, Sanders DS, Hadjivassiliou M.

Postgrad Med. 2019 Aug 6:1-5. doi: 10.1080/00325481.2019.1650609. [Epub ahead of print]

PMID:
31359810
2.

Is 1H-MR spectroscopy useful as a diagnostic aid in MSA-C?

Kadodwala VH, Hadjivassiliou M, Currie S, Skipper N, Hoggard N.

Cerebellum Ataxias. 2019 Jul 5;6:7. doi: 10.1186/s40673-019-0099-0. eCollection 2019.

3.

Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Michaelides A, Hadden RDM, Sarrigiannis PG, Hadjivassiliou M, Zis P.

Pain Ther. 2019 Jun 14. doi: 10.1007/s40122-019-0128-y. [Epub ahead of print] Review.

PMID:
31201680
4.

A Population Survey of Dietary Attitudes towards Gluten.

Croall ID, Trott N, Rej A, Aziz I, O'Brien DJ, George HA, Hossain MY, Marks LJS, Richardson JI, Rigby R, Hadjivassiliou M, Hoggard N, Sanders DS.

Nutrients. 2019 Jun 5;11(6). pii: E1276. doi: 10.3390/nu11061276.

5.

A Novel Pathogenic Variant in MT-CO2 Causes an Isolated Mitochondrial Complex IV Deficiency and Late-Onset Cerebellar Ataxia.

Zierz CM, Baty K, Blakely EL, Hopton S, Falkous G, Schaefer AM, Hadjivassiliou M, Sarrigiannis PG, Ng YS, Taylor RW.

J Clin Med. 2019 Jun 4;8(6). pii: E789. doi: 10.3390/jcm8060789.

6.

Tremor after long term lithium treatment; is it cortical myoclonus?

Sarrigiannis PG, Zis P, Unwin ZC, Blackburn DJ, Hoggard N, Zhao Y, Billings SA, Khan AA, Yianni J, Hadjivassiliou M.

Cerebellum Ataxias. 2019 May 22;6:5. doi: 10.1186/s40673-019-0100-y. eCollection 2019.

7.

Nocebo in cerebellar ataxia: A systematic review and meta-analysis of placebo-controlled clinical trials.

Alam JM, Hadjivassiliou M, Zis P.

J Neurol Sci. 2019 Jun 15;401:112-117. doi: 10.1016/j.jns.2019.04.039. Epub 2019 Apr 30.

PMID:
31075682
8.

Diagnosis and management of progressive ataxia in adults.

de Silva RN, Vallortigara J, Greenfield J, Hunt B, Giunti P, Hadjivassiliou M.

Pract Neurol. 2019 Jun;19(3):196-207. doi: 10.1136/practneurol-2018-002096. Epub 2019 May 2. Review.

9.

Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials.

Zis P, Shafique F, Hadjivassiliou M, Blackburn D, Venneri A, Iliodromiti S, Mitsikostas DD, Sarrigiannis PG.

Neuromodulation. 2019 Mar 21. doi: 10.1111/ner.12946. [Epub ahead of print]

PMID:
30896060
10.

Neurologic Deficits in Patients With Newly Diagnosed Celiac Disease Are Frequent and Linked With Autoimmunity to Transglutaminase 6.

Hadjivassiliou M, Croall ID, Zis P, Sarrigiannis PG, Sanders DS, Aeschlimann P, Grünewald RA, Armitage PA, Connolly D, Aeschlimann D, Hoggard N.

Clin Gastroenterol Hepatol. 2019 Mar 16. pii: S1542-3565(19)30278-2. doi: 10.1016/j.cgh.2019.03.014. [Epub ahead of print]

PMID:
30885888
11.

Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease.

Zis P, Hadjivassiliou M.

Curr Treat Options Neurol. 2019 Feb 26;21(3):10. doi: 10.1007/s11940-019-0552-7. Review.

PMID:
30806821
12.

Neurological Manifestations of Neuropathy and Ataxia in Celiac Disease: A Systematic Review.

Mearns ES, Taylor A, Thomas Craig KJ, Puglielli S, Leffler DA, Sanders DS, Lebwohl B, Hadjivassiliou M.

Nutrients. 2019 Feb 12;11(2). pii: E380. doi: 10.3390/nu11020380.

13.

Electrophysiological determinants of the clinical severity of axonal peripheral neuropathy.

Zis P, Hadjivassiliou M, Rao DG, Sarrigiannis PG.

Muscle Nerve. 2019 Apr;59(4):491-493. doi: 10.1002/mus.26425. Epub 2019 Feb 11.

PMID:
30680742
14.

Reversible Corticobasal Syndrome due to Coeliac Disease.

Paramanandam V, Hadjivassiliou M, Olszewska DA, Munteanu T, Williams L, Magennis B, Fearon C, O'Connell M, Sarrigiannis P, Lynch T.

Mov Disord Clin Pract. 2018 Oct 23;5(5):551-554. doi: 10.1002/mdc3.12659. eCollection 2018 Sep-Oct. No abstract available.

PMID:
30637273
15.

Novel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations.

Hewamadduma CA, Hoggard N, O'Malley R, Robinson MK, Beauchamp NJ, Segamogaite R, Martindale J, Rodgers T, Rao G, Sarrigiannis P, Shanmugarajah P, Zis P, Sharrack B, McDermott CJ, Shaw PJ, Hadjivassiliou M.

Neurol Genet. 2018 Oct 24;4(6):e279. doi: 10.1212/NXG.0000000000000279. eCollection 2018 Dec. Erratum in: Neurol Genet. 2018 Dec 03;4(6):e300.

16.

Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life.

Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M.

Brain Behav. 2019 Jan;9(1):e01171. doi: 10.1002/brb3.1171. Epub 2018 Nov 25.

17.

Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy.

Zis P, McHugh PC, Manca M, Sarrigiannis PG, Rao DG, Hadjivassiliou M.

J Mol Neurosci. 2018 Dec;66(4):547-551. doi: 10.1007/s12031-018-1200-5. Epub 2018 Oct 22.

18.

Headache Associated with Coeliac Disease: A Systematic Review and Meta-Analysis.

Zis P, Julian T, Hadjivassiliou M.

Nutrients. 2018 Oct 6;10(10). pii: E1445. doi: 10.3390/nu10101445.

19.

The Significance of Low Titre Antigliadin Antibodies in the Diagnosis of Gluten Ataxia.

Hadjivassiliou M, Grünewald RA, Sanders DS, Zis P, Croal I, Shanmugarajah PD, Sarrigiannis PG, Trott N, Wild G, Hoggard N.

Nutrients. 2018 Oct 5;10(10). pii: E1444. doi: 10.3390/nu10101444.

20.

Gluten sensitivity and epilepsy: a systematic review.

Julian T, Hadjivassiliou M, Zis P.

J Neurol. 2019 Jul;266(7):1557-1565. doi: 10.1007/s00415-018-9025-2. Epub 2018 Aug 23. Review.

21.

Peripheral neuropathic pain in idiopathic Parkinson's disease: Prevalence and impact on quality of life; a case controlled study.

Adewusi JK, Hadjivassiliou M, Vinagre-Aragón A, O'Connor KR, Khan A, Grünewald RA, Zis P.

J Neurol Sci. 2018 Sep 15;392:3-7. doi: 10.1016/j.jns.2018.06.022. Epub 2018 Jun 25.

PMID:
30097149
22.

Movement Disorders Related to Gluten Sensitivity: A Systematic Review.

Vinagre-Aragón A, Zis P, Grunewald RA, Hadjivassiliou M.

Nutrients. 2018 Aug 8;10(8). pii: E1034. doi: 10.3390/nu10081034. Review.

23.

An unusual case of inflammatory meningitis in a young man with systemic lupus erythematosus.

Smith R, Hadjivassiliou M, Hoggard N, Kuet KP, Kilding R, Akil M.

Lupus. 2018 Oct;27(11):1864-1866. doi: 10.1177/0961203318791760. Epub 2018 Aug 9.

PMID:
30092733
24.

Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet.

Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M.

J Neurol. 2018 Oct;265(10):2231-2236. doi: 10.1007/s00415-018-8978-5. Epub 2018 Jul 21.

PMID:
30032386
25.

Office-Based Point of Care Testing (IgA/IgG-Deamidated Gliadin Peptide) for Celiac Disease.

Lau MS, Mooney PD, White WL, Rees MA, Wong SH, Hadjivassiliou M, Green PHR, Lebwohl B, Sanders DS.

Am J Gastroenterol. 2018 Aug;113(8):1238-1246. doi: 10.1038/s41395-018-0143-3. Epub 2018 Jun 19.

PMID:
29915400
26.

Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus.

Leeds JS, Hadjivassiliou M, Tesfaye S, Sanders DS.

BMJ Open Diabetes Res Care. 2018 May 29;6(1):e000514. doi: 10.1136/bmjdrc-2018-000514. eCollection 2018.

27.

Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study.

Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M.

Nutrients. 2018 May 23;10(6). pii: E662. doi: 10.3390/nu10060662.

28.

Sensory neuropathic symptoms in idiopathic Parkinson's disease: prevalence and impact on quality of life.

Adewusi JK, Hadjivassiliou M, Vinagre-Aragón A, O'Connor KR, Khan A, Grünewald RA, Zis P.

Acta Neurol Belg. 2018 Sep;118(3):445-450. doi: 10.1007/s13760-018-0947-3. Epub 2018 May 23.

PMID:
29796943
29.

Exaggerated startle in post-infectious opsoclonus myoclonus syndrome.

Blackburn DJ, Forbes M, Unwin Z, Hoggard N, Hadjivassiliou M, Sarrigiannis PG.

Clin Neurophysiol. 2018 Jul;129(7):1372-1373. doi: 10.1016/j.clinph.2018.03.026. Epub 2018 Apr 13. No abstract available.

30.

Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials.

Zis P, Hadjivassiliou M, Sarrigiannis PG, Jenkins TM, Mitsikostas DD.

J Neurol Sci. 2018 May 15;388:79-83. doi: 10.1016/j.jns.2018.03.009. Epub 2018 Mar 7.

PMID:
29627036
31.

Axillary motor nerve conduction study: Description of technique and provision of normative data.

Zis P, Hadjivassiliou M, Rao DG.

J Electromyogr Kinesiol. 2018 Apr;39:95-98. doi: 10.1016/j.jelekin.2018.02.002. Epub 2018 Feb 10.

PMID:
29471183
32.

Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics.

Shanmugarajah PD, Hoggard N, Aeschlimann DP, Aeschlimann PC, Dennis GJ, Howell SJ, Reuber M, Grünewald RA, Hadjivassiliou M.

Seizure. 2018 Mar;56:26-30. doi: 10.1016/j.seizure.2018.01.019. Epub 2018 Feb 2.

33.

Characterization of Paroxysmal Gluten-Sensitive Dyskinesia in Border Terriers Using Serological Markers.

Lowrie M, Garden OA, Hadjivassiliou M, Sanders DS, Powell R, Garosi L.

J Vet Intern Med. 2018 Mar;32(2):775-781. doi: 10.1111/jvim.15038. Epub 2018 Feb 9.

34.

The cortical focus in childhood absence epilepsy; evidence from nonlinear analysis of scalp EEG recordings.

Sarrigiannis PG, Zhao Y, He F, Billings SA, Baster K, Rittey C, Yianni J, Zis P, Wei H, Hadjivassiliou M, Grünewald R.

Clin Neurophysiol. 2018 Mar;129(3):602-617. doi: 10.1016/j.clinph.2017.11.029. Epub 2018 Jan 8.

35.

Rapid neurophysiological screening for sensory ganglionopathy: A novel approach.

Zis P, Hadjivassiliou M, Sarrigiannis PG, Barker ASJE, Rao DG.

Brain Behav. 2017 Nov 24;7(12):e00880. doi: 10.1002/brb3.880. eCollection 2017 Dec.

36.

Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?

Zis P, Sarrigiannis PG, Rao DG, Hoggard N, Sanders DS, Hadjivassiliou M.

Cerebellum Ataxias. 2017 Dec 22;4:20. doi: 10.1186/s40673-017-0079-1. eCollection 2017.

37.

Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.

Hadjivassiliou M.

CNS Neurol Disord Drug Targets. 2017 Dec 20. doi: 10.2174/1871527317666171221110548. [Epub ahead of print]

PMID:
29268693
38.

The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.

Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, De Magistris L, Dieterich W, Di Liberto D, Elli L, Fasano A, Hadjivassiliou M, Kurien M, Lionetti E, Mulder CJ, Rostami K, Sapone A, Scherf K, Schuppan D, Trott N, Volta U, Zevallos V, Zopf Y, Sanders DS.

Nutrients. 2017 Nov 21;9(11). pii: E1268. doi: 10.3390/nu9111268. Review.

39.

Anti-MAG associated cerebellar ataxia and response to rituximab.

Zis P, Rao DG, Hoggard N, Sarrigiannis PG, Hadjivassiliou M.

J Neurol. 2018 Jan;265(1):115-118. doi: 10.1007/s00415-017-8675-9. Epub 2017 Nov 20.

PMID:
29159464
40.

The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.

Lau MS, Mooney PD, White WL, Rees MA, Wong SH, Kurien M, Trott N, Leffler DA, Hadjivassiliou M, Sanders DS.

Am J Gastroenterol. 2017 Dec;112(12):1859-1867. doi: 10.1038/ajg.2017.357. Epub 2017 Oct 10.

41.

Gordon Holmes syndrome: finally genotype meets phenotype.

Mehmood S, Hoggard N, Hadjivassiliou M.

Pract Neurol. 2017 Dec;17(6):476-478. doi: 10.1136/practneurol-2017-001674. Epub 2017 Sep 28.

PMID:
28972031
42.

Mutations in TGM6 induce the unfolded protein response in SCA35.

Tripathy D, Vignoli B, Ramesh N, Polanco MJ, Coutelier M, Stephen CD, Canossa M, Monin ML, Aeschlimann P, Turberville S, Aeschlimann D, Schmahmann JD, Hadjivassiliou M, Durr A, Pandey UB, Pennuto M, Basso M.

Hum Mol Genet. 2017 Oct 1;26(19):3749-3762. doi: 10.1093/hmg/ddx259.

PMID:
28934387
43.

Transglutaminase 6 antibodies in gluten neuropathy.

Zis P, Rao DG, Sarrigiannis PG, Aeschlimann P, Aeschlimann DP, Sanders D, Grünewald RA, Hadjivassiliou M.

Dig Liver Dis. 2017 Nov;49(11):1196-1200. doi: 10.1016/j.dld.2017.08.019. Epub 2017 Aug 10.

PMID:
28886934
44.

Novel POLG variants associated with late-onset de novo status epilepticus and progressive ataxia.

Ng YS, Powell H, Hoggard N, Turnbull DM, Taylor RW, Hadjivassiliou M.

Neurol Genet. 2017 Aug 9;3(5):e181. doi: 10.1212/NXG.0000000000000181. eCollection 2017 Oct. No abstract available.

45.

Effect of gluten-free diet on cerebellar MR spectroscopy in gluten ataxia.

Hadjivassiliou M, Grünewald RA, Sanders DS, Shanmugarajah P, Hoggard N.

Neurology. 2017 Aug 15;89(7):705-709. doi: 10.1212/WNL.0000000000004237. Epub 2017 Jul 19.

PMID:
28724585
46.

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis.

Zis P, Paladini A, Piroli A, McHugh PC, Varrassi G, Hadjivassiliou M.

Pain Ther. 2017 Dec;6(2):143-151. doi: 10.1007/s40122-017-0076-3. Epub 2017 Jul 1. Review.

47.

Peripheral neuropathy in idiopathic Parkinson's disease: A systematic review.

Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M.

J Neurol Sci. 2017 Jul 15;378:204-209. doi: 10.1016/j.jns.2017.05.023. Epub 2017 May 11. Review.

PMID:
28566165
48.

A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease.

Zis P, Reilly MM, Rao DG, Tomaselli P, Rossor AM, Hadjivassiliou M.

J Peripher Nerv Syst. 2017 Sep;22(3):224-225. doi: 10.1111/jns.12222. No abstract available.

49.

Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure.

De Leo L, Aeschlimann D, Hadjivassiliou M, Aeschlimann P, Salce N, Vatta S, Ziberna F, Cozzi G, Martelossi S, Ventura A, Not T.

J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):64-68. doi: 10.1097/MPG.0000000000001642.

PMID:
28542044
50.

Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma.

Zis P, Rao DG, Wagner BE, Nicholson-Goult L, Hoggard N, Hadjivassiliou M.

Cerebellum Ataxias. 2017 Jan 5;4:1. doi: 10.1186/s40673-016-0060-4. eCollection 2017.

Supplemental Content

Loading ...
Support Center